Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zutectra in Liver Transplanted Patients
NCT01856413Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Dec 2012
- Primary completion
- Sep 2014
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 4
01
Overview
A Phase 3 trial of Fovepta in hepatitis B (HBV), sponsored by Biotest AG. Started Dec 2012; status: completed.
02
Drugs
Fovepta
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01856413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856413.